ÂÜÀòÂÒÂ×

Ben Eldridge co-founded Nutcracker Therapeutics, Inc. and serves as its Chief Technology Officer. As Nutcracker’s systems architect, Ben leads the development of a device-based platform for large scale synthesis of nucleic acids. Prior to Nutcracker, Ben served in executive management roles at FormFactor, Inc., most recently as Chief Information Officer, previously as Chief Technology Officer. Prior to joining FormFactor, Ben held engineering positions at the IBM TJ Watson Research Center in Yorktown Heights, NY. Ben was awarded a B.S. in Electrical Engineering from Union College and an M.S. in Physics from Rensselaer Polytechnic Institute. Ben holds over 200 US patents covering inventions in Electrical, Mechanical and Micro Systems Engineering.